Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3.
(Q42797699)
scientific article published on December 2000
scientific article published on December 2000
Language:
other details
| description | scientific article published on December 2000 |
External Links
| (P356) |
10.1074/JBC.M006657200
|
| (P698) |
10973975
|